BRAF V600 COLORECTAL CANCER

Clinical trials for BRAF V600 COLORECTAL CANCER explained in plain language.

Never miss a new study

Get alerted when new BRAF V600 COLORECTAL CANCER trials appear

Sign up with your email to follow new studies for BRAF V600 COLORECTAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Terminated 1

Four-Drug attack on Tough-to-Treat colon cancer

Disease control Recruiting now

This study is testing a new combination of four drugs for adults with advanced colorectal cancer that has a specific genetic change called BRAF V600E. The goal is to see if this combination is safe and more effective than past treatments for this hard-to-treat cancer. About 20 pa…

Matched conditions: BRAF V600 COLORECTAL CANCER

Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control

Last updated Mar 30, 2026 14:31 UTC

BRAF V600 COLORECTAL CANCER

Get alerted when new BRAF V600 COLORECTAL CANCER trials appear

Four-Drug attack on Tough-to-Treat colon cancer